GlassScriptPhysician profile
Maha M Ghalib
NPI 1760584254
$4,344.48
in general payments reported to CMS, 2019-2025
39 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $14.56 · 2021: $961 · 2022: $917 · 2023: $742 · 2024: $804 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,995.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $690.65 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $626.25 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $591.20 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $354.32 | 2021-2025 | Breztri |
| Novo Nordisk INC | $311.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $292.87 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $243.93 | 2023-2024 | Dupixent |
| Genzyme Corporation | $125.00 | 2021 | |
| Lilly USA, LLC | $102.38 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Actelion Pharmaceuticals US, INC. | $92.94 | 2022-2024 | Uptravi, Opsumit |
| Exact Sciences Corporation | $79.34 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $59.07 | 2021-2023 | |
| Astellas Pharma US INC | $58.41 | 2021-2023 | Veozah |
| Dexcom, INC. | $58.38 | 2024-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.07 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maha Ghalib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.